TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 3:59 PM
1.77
-1.94%
After-hours: Aug 15, 2025, 05:29 PM EDT
TScan Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.08M | 2.17M | 665K | 1.05M | 536K | 566K | 7.21M | 3.89M | 3.15M | 6.8M | 1K | 3.36M | 4.06M | 3.02M | 2.85M | 2.41M | 2.85M | 2.03M |
Cost of Revenue | n/a | n/a | 711K | 1.03M | 1.12M | 1.25M | 1.28M | 1.29M | 1.3M | 1.5M | 1.48M | n/a | 1.21M | 1.2M | 1.14M | 14.21M | 10.8M | 7.34M |
Gross Profit | 3.08M | 2.17M | -46K | 1.05M | -580K | -688K | 5.93M | 2.6M | 1.85M | 5.3M | -1.48M | 3.36M | 2.85M | 1.83M | 1.71M | -11.79M | -7.95M | -5.31M |
Operating Income | -38.65M | -36.25M | -36.71M | -32.62M | -34.11M | -31.37M | -21.36M | -24.75M | -24.61M | -22.74M | -18.65M | -16.58M | -15.25M | -16.15M | -14.2M | -15.84M | -10.68M | -7.92M |
Interest Income | 2.39M | 2.8M | 2.78M | 3.69M | 3.4M | 2.19M | 2.6M | 2.73M | 1.53M | 1.14M | 901K | 534K | 149K | 7K | 2K | 3K | 5K | 6K |
Pretax Income | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M | -7.91M |
Net Income | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.8M | -16.25M | -14.95M | -16.15M | -14.2M | -15.84M | -10.67M | -7.91M |
Selling & General & Admin | 8.92M | 8.46M | 7.29M | 7.41M | 7.77M | 7.08M | 4.88M | 5.89M | 6.53M | 7.77M | 6.14M | 4.91M | 4.81M | 4.49M | 4.45M | 4.05M | 2.73M | 2.61M |
Research & Development | 32.63M | 29.79M | 29.35M | 26.26M | 26.88M | 24.86M | 22.41M | 22.74M | 21.23M | 21.78M | 15.6M | 15.03M | 14.49M | 14.69M | 12.61M | 14.21M | 10.8M | 7.34M |
Other Expenses | 176K | 176K | 17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 900K | n/a | n/a | 7K | n/a | n/a | n/a | n/a |
Operating Expenses | 41.73M | 38.42M | 36.67M | 33.67M | 34.65M | 31.94M | 27.29M | 28.64M | 27.76M | 29.55M | 21.74M | 19.94M | 19.3M | 19.18M | 17.06M | 18.25M | 13.53M | 9.95M |
Interest Expense | 689K | 679K | 784K | 958K | 952K | 959K | 852K | 982K | 969K | 956K | 975K | 201K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.73M | 38.42M | 37.38M | 33.67M | 34.65M | 31.94M | 28.57M | 28.64M | 27.76M | 29.55M | 21.74M | 19.94M | 19.3M | 19.18M | 17.06M | 18.25M | 13.53M | 9.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 74K | n/a | -149K | -7K | -2K | -3K | -5K | -6K |
Shares Outstanding (Basic) | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M | 24.94M |
Shares Outstanding (Diluted) | 129.73M | 129.68M | 120.79M | 118.7M | 113.43M | 94.88M | 94.84M | 94.83M | 47.21M | 24.23M | 24.08M | 24.07M | 24.06M | 23.97M | 23.91M | 23.77M | 23.97M | 24.94M |
EPS (Basic) | -0.28 | -0.26 | -0.3 | -0.25 | -0.28 | -0.32 | -0.21 | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 | -0.62 | -0.67 | -0.59 | -0.67 | -0.45 | -0.32 |
EPS (Diluted) | -0.28 | -0.26 | -0.3 | -0.25 | -0.28 | -0.32 | -0.21 | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 | -0.62 | -0.67 | -0.59 | -0.67 | -0.45 | -0.32 |
EBITDA | -35.56M | -32.77M | -34.31M | -27.9M | -29.59M | -27.93M | -17.48M | -20.73M | -21.78M | -20.11M | -16.26M | -14.79M | -13.89M | -14.96M | -13.06M | -14.78M | -10.02M | -7.45M |
EBIT | -36.26M | -33.45M | -35.02M | -28.93M | -30.71M | -29.18M | -18.76M | -22.02M | -23.08M | -21.61M | -17.75M | -16.04M | -15.1M | -16.16M | -14.2M | -15.84M | -10.68M | -7.92M |
Depreciation & Amortization | 698K | 678K | 711K | 1.03M | 1.12M | 1.25M | 1.28M | 1.29M | 1.3M | 1.5M | 1.48M | 1.25M | 1.21M | 1.2M | 1.14M | 1.06M | 661K | 469K |